The Vaxaas nano patch may well be used in the next trials. That would be an interesting validation of both technologies.
I wonder what the commercials around that might look like? Would we be the first significant use?
Trials will at some point need to be on the whole system, not just the vaccine. I'm intrigued if that will start from phase 2b.
- Forums
- ASX - By Stock
- AVR
- Vaxxas secures funding interest to see if professor Fraser utilizes nanopatch
Vaxxas secures funding interest to see if professor Fraser utilizes nanopatch, page-115
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVR (ASX) to my watchlist
|
|||||
Last
$18.00 |
Change
0.000(0.00%) |
Mkt cap ! $346.0M |
Open | High | Low | Value | Volume |
$18.00 | $18.10 | $17.70 | $58.64K | 3.27K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 109 | $18.00 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$18.10 | 700 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 48 | 17.750 |
1 | 26 | 17.650 |
1 | 200 | 17.560 |
1 | 500 | 17.550 |
1 | 1 | 17.510 |
Price($) | Vol. | No. |
---|---|---|
18.100 | 700 | 1 |
18.300 | 150 | 1 |
18.500 | 43 | 1 |
18.690 | 550 | 1 |
18.750 | 143 | 1 |
Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
Featured News
TLX
Telix jumps 11.6% as US government indicates proposed medicare changes won't affect prostate cancer drug
SKS
SKS Technologies wins US$90M award to supply power to international hyperscale data centre in Melbourne
AVR (ASX) Chart |